| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 200.14B | 209.60B | 180.00B | 174.96B | 122.29B | 112.06B |
| Gross Profit | 126.44B | 120.87B | 109.25B | 141.14B | 108.89B | 96.39B |
| EBITDA | 39.34B | 42.53B | 34.21B | 32.70B | 29.87B | 25.38B |
| Net Income | 27.92B | 27.43B | 21.39B | 20.49B | 18.37B | 14.42B |
Balance Sheet | ||||||
| Total Assets | 11.24T | 11.05T | 10.76T | 9.85T | 10.21T | 9.15T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 0.00 | 1.42T | 1.51T | 1.76T | -1.03T |
| Total Debt | 2.69T | 1.89T | 1.67T | 1.08T | 1.64T | 1.17T |
| Total Liabilities | 10.67T | 10.50T | 10.18T | 9.32T | 9.66T | 8.59T |
| Stockholders Equity | 566.12B | 542.37B | 581.11B | 527.95B | 552.41B | 562.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 190.50B | -143.96B | -2.10B | -7.53B | 17.54B |
| Operating Cash Flow | 0.00 | 201.50B | -140.46B | 46.00M | -4.90B | 20.14B |
| Investing Cash Flow | 0.00 | -265.07B | -198.39B | 119.18B | -335.52B | -515.57B |
| Financing Cash Flow | 0.00 | 253.74B | 248.12B | -368.95B | 1.10T | 929.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥554.37B | 9.62 | ― | 3.15% | 12.71% | 71.94% | |
70 Outperform | ¥527.58B | 15.28 | 6.09% | 2.93% | 5.87% | 50.22% | |
70 Outperform | ¥574.45B | 9.42 | ― | 3.21% | 19.82% | 29.59% | |
69 Neutral | ¥761.27B | 9.74 | ― | 1.41% | 28.83% | 105.24% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥568.39B | 10.79 | 5.53% | 2.02% | 12.96% | 44.62% | |
65 Neutral | ¥562.89B | 7.73 | ― | 2.93% | 9.27% | 19.72% |